Mr Richard Godfrey
Chief Executive Officer
drug development and commercialisation
Kosmo Science
Norway
Biography
Richard Godfrey joined BerGenBio as Chief Executive Officer in 2008. He has more than 25 years’ industry experience leading many international drug development and commercialisation partnerships. Formerly he served as Chief Executive Officer of Aenova Inc., a specialist biopharmaceutical company. Prior to this he was the Managing Director of DCC Healthcare Ltd and previously he held positions of increasing responsibility at Catalant, Eli Lilly and Reckitt Benckiser in R&D and commercial roles.
Research Interest
He qualified as a Pharmacist from Liverpool University and received his M.B.A. from Bath University.
